Table 1.
Baseline characteristics for the national HF cohort for select years 2002, 2007, 2013 from the National Inpatient Sample.
| 2002 | 2007 | 2013 | |
|---|---|---|---|
| Age | 72.90 | 72.48 | 72.27 |
| Female | 54.74% | 51.34% | 49.03% |
| Race/Ethnicity | |||
| White | 70.40% | 66.55% | 64.34% |
| Black | 18.01% | 20.09% | 19.23% |
| Hispanic | 7.13% | 7.82% | 7.37% |
| Asian/PI | 1.59% | 1.80% | 1.91% |
| Census Region | |||
| New England | 4.77% | 6.56% | 4.98% |
| Mid Atlantic | 16.30% | 13.09% | 15.03% |
| East North Central | 16.42% | 18.48% | 16.75% |
| West North Central | 7.23% | 6.06% | 6.18% |
| South Atlantic | 26.30% | 25.06% | 21.92% |
| East South Central | 5.95% | 4.48% | 7.69% |
| West South Central | 7.92% | 10.43% | 11.30% |
| Mountain | 2.03% | 3.66% | 4.19% |
| Pacific | 13.08% | 12.17% | 11.96% |
| Primary Payer | |||
| Medicare | 76.35% | 74.11% | 74.85% |
| Medicaid | 6.56% | 7.46% | 8.08% |
| Private Insurance | 13.11% | 12.78% | 11.08% |
| Self-Pay | 2.29% | 3.29% | 3.48% |
| No Charge | 0.21% | 0.41% | 0.38% |
| Other | 1.42% | 1.80% | 2.00% |
| Comorbidities† | |||
| HTN | 58.73% | 65.39% | 70.92% |
| CAD | 27.49% | 29.54% | 32.23% |
| Atrial fibrillation | 12.94% | 15.20% | 17.77% |
| Obese | 18.72% | 20.18% | 32.40% |
| Valve Disease | 16.80% | 19.82% | 22.29% |
| VT | 5.09% | 6.08% | 7.14% |
| AMI | 1.68% | 1.89% | 2.28% |
| PVD | 4.14% | 4.88% | 6.60% |
| DM | 33.23% | 35.22% | 38.81% |
| COPD | 17.31% | 17.65% | 17.74% |
| Anemia | 19.17% | 22.42% | 30.01% |
| Fluid/Electrolyte | 19.10% | 24.12% | 31.87% |
PI = Pacific Islander, HTN = hypertension, CAD = coronary artery disease, VT = ventricular tachycardia, AMI = acute myocardial infarction, PVD = peripheral vascular disease, DM = diabetes mellitus, COPD = chronic obstructive pulmonary disease.
†
Age-standardized proportions to 2000 U.S. standard population.